-epi-12β-hydroxyfroside, a new cardenolide, induces ... · Theranostics ...
THURSDAY | October 22, 2020 · e-Poster Presentation Session 1 Oncology & Theranostics PET...
Transcript of THURSDAY | October 22, 2020 · e-Poster Presentation Session 1 Oncology & Theranostics PET...
33rd Annual Congress of the European Association of Nuclear Medicine | October 22 - 30, 2020
O C T O B E R 2 2 – 3 0 , 2 0 2 0 | V I R T U A L 3O C T O B E R 2 2 – 3 0 , 2 0 2 0 | V I R T U A L2
L E T T E R O F I N V I T AT I O N
EA
NM
’20
WO
RL
D L
EA
DIN
G M
EE
TIN
G
EA
NM
’20
WO
RL
D L
EA
DIN
G M
EE
TIN
GT A B L E O F C O N T E N T S
Imprint 3Letter of Invitation by the Congress Chair 4EANM Board 6Scientific Programme Council 8
SCIENTIFIC & TECHNOLOGIST‘S PROGRAMME
» Programme Overview 10 » Session Descriptions 22 » Mid-Congress Symposia 24 » Plenary Sessions 26 » Continuing Medical Education/CME Sessions 28 » Joint Symposia 30 » EANM Young Daily Forum 32 » Pitfalls & Artefacts Sessions 33 » Teaching Sessions 34 » Cutting Edge Science Track 36 » M2M – The 7th “From Molecule to Man” Track 37 » Letter of Invitation by the Chair of the Technologist Committee 38 » Technologists‘ Track 40 » e-Poster area + On Demand Sessions 42 » Awards 43
EXHIBITION
» Industry Exhibition 45
REGISTRATION
» Fees 46
GENERAL INFORMATION 48
USEFUL CONTACTS 52
TA B L E O F C O N T E N T S
PUBLISHER European Association of Nuclear Medicine Schmalzhofgasse 26, 1060 Vienna, Austria Phone: +43 1 890 44 27 Fax: +43 1 890 44 27-9 Email: [email protected] Web: www.eanm.org
EDITORS Stefano Fanti, EANM Congress Chair 2020-2022 Andreas Felser, Susanne Koebe, EANM Executive Office
CONTENT No responsibility is taken for the correctness of this information. Information as per time of publication, March 2020.
LAYOUT & DESIGN Olga Dogadina, EANM Executive Office
I M P R I N T
O C T O B E R 2 2 – 3 0 , 2 0 2 0 | V I R T U A L 5O C T O B E R 2 2 – 3 0 , 2 0 2 0 | V I R T U A L4
EA
NM
’20
WO
RL
D L
EA
DIN
G M
EE
TIN
G
EA
NM
’20
WO
RL
D L
EA
DIN
G M
EE
TIN
GL E T T E R O F I N V I T AT I O NL E T T E R O F I N V I T AT I O N
On behalf of the European Association of Nuclear Medicine, it is my great honour to invite you to the 33rd Annual EANM Congress, which will take place virtually from 22 to 30 October 2020.
Nuclear Medicine keeps on growing in many clinical areas, from diagnostic imaging to therapy: our procedures are increasingly being incorporated into clinical practice, in a variety of settings and diseases. This success is mostly related to a peculiar characteristic of our specialty, namely the functional approach to medicine. PET imaging works so well because of the unique functional information provided to clinicians, and this feature is the key to the ongoing rapid diffusion of Nuclear Medicine.
In recent years, the status of the EANM Congress as the world-leading meeting in Nuclear Medicine has been firmly established. The number of attendees in 2019 exceeded that in any previous year, with more than 6950 participants, but we are working to make the 2020 event even bigger, more memorable, and virtual.
EANM cares for its members, participants and patients, with safety being our primary concern as COVID-19 continues to pose a major health threat worldwide. Therefore, it was decided that it is in the best interest of the entire NM community to go virtual only.
The Virtual EANM Congress will still have all the features that made the event successful in the past. The usual excellent tracks and sessions, from CME to joint sessions, have already been confirmed. A
number of newer features are also being planned and we will have a new format for the plenary sessions, new top-rated oral presentation sessions and a new ‘Top Trials’ session.
A further characteristic of our Congress is its multidisciplinarity, and this will be emphasised in 2020, with a number of sessions bringing together physicians from many specialties as well as specialists in radiochemistry and pharmacy, physicists and other professionals. In addition, a dedicated track for technologists will be provided.
If all of this still isn’t enough to motivate you to attend the EANM’20 Congress virtually, we are working on providing some extra entertainment to make your virtual experience even more fun. This will include a daily nuclear quiz, daily programme highlights’ announcements, games and social opportunities.
Stefano FantiEANM Congress Chair 2020–2022
LETTER OFI N V I TAT I O Nby the Congress Chair
Stefano FantiCONGRESS CHAIR 2020-2022
O C T O B E R 2 2 – 3 0 , 2 0 2 0 | V I R T U A L 7O C T O B E R 2 2 – 3 0 , 2 0 2 0 | V I R T U A L6
EA
NM
’20
WO
RL
D L
EA
DIN
G M
EE
TIN
G
EA
NM
’20
WO
RL
D L
EA
DIN
G M
EE
TIN
GB O A R DB O A R D
The Board is the highest executive level of the association, creating and safeguarding the EANM’s vision to help the specialty continue to thrive.Promoting scientific excellence is one of the corner stones of the EANM’s strategy that is proudly showcasted at the annual congress.
EANMBOARD
Wim OyenPRESIDENT 2019 - 2020
2
Jolanta KunikowskaPRESIDENT ELECT 2019 - 2020
Roland HustinxCOMMITTEE COORDINATOR 2019 - 2020
Stefano FantiCONGRESS CHAIR 2020 - 2022
Paola Anna ErbaEDUCATION CHAIR 2020 - 2022
Wolfgang WadsakSECRETARY/TREASURER 2019 - 2020
Michael LassmannSCIENTIFIC LIAISON OFFICER 2019 - 2020
98
S C I E N T I F I C P R O G R A M M ES C I E N T I F I C P R O G R A M M EP
RO
GR
AM
ME
OV
ER
VI
EW
| O
CT
OB
ER
22
–3
0,
20
20
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G
SCIENTIFICPROGRAMMECO U N C I LC O N G R E S S C H A I R Stefano Fanti Italy
C O M M I T T E E R E P R E S E N TAT I V E C O U N T R Y
B O N E & J O I N T Salvatore Annunziata Italy
C A R D I O V A S C U L A R Fabien Hyafil France
D O S I M E T R Y Mark W. Konijnenberg Netherlands
D R U G D E V E L O P M E N T Johnny Vercouillie France
I N F L A M M AT I O N & I N F E C T I O N Giorgio Treglia Switzerland
N E U R O I M A G I N G Henryk Barthel Germany
O N C O L O G Y & T H E R A N O S T I C S Ken Herrmann Germany
PA E D I AT R I C S Pietro Zucchetta Italy
P H Y S I C S John Dickson United Kingdom
R A D I AT I O N P R O T E C T I O N Lídia Cunha Portugal
R A D I O P H A R M A C Y Peter Laverman Netherlands
T E C H N O L O G I S T Andrea Santos Portugal
T H Y R O I D Martha Hoffmann Austria
T R A N S L AT I O N A L M O L E C U L A R Fijs van Leeuwen NetherlandsI M A G I N G A N D T H E R A P Y
1110
S C I E N T I F I C P R O G R A M M ES C I E N T I F I C P R O G R A M M EP
RO
GR
AM
ME
OV
ER
VI
EW
| O
CT
OB
ER
22
–3
0,
20
20
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G
Time (CEST) Channel 1 Channel 2 Channel 3 Channel 4 Channel 5 Channel 6 Channel 7 Channel 8 Channel 9 Channel 10 Channel 11 Time (CEST)
13:00 - 13:25
Welcome and Practical Info - A Virtual Introduction
13:00 - 13:25
13:25 - 13:30
13:25 - 13:30
13:30-15:00
101
CME 1Translational Molecular Imaging and Therapy +
Oncology & Theranostics Committee
Radar on Gynaecological Cancers
102
Joint Symposium 1Drug Development Committee / EFMC
Imaging Neuroinflammation
103
Joint Symposium 2TMIT + Drug
Development + Radiopharmacy +
Oncology & Theranostics Committee / WMISNano- and Micro-
Particles in Nuclear Medicine (Incl.
Radioembolisation)
104
Technologists‘ Opening (13:30-13:40)
CTE 1(13:40-15:00)
Technologist CommitteeTech Guide Launch
105
M2M Track TROP SessionRadiopharmacy +
Translational Molecular Imaging and Therapy
Committee
Translational Oncology Imaging
106
Cutting Edge Science Track TROP Session
Physics Committee
Quantification
107
Pitfalls & Artefacts 1
Neuroimaging Committee
Unexpected Findings in Brain Imaging
108
Clinical Oncology Track
Featured Session Oncology & Theranostics
Committee
Prostate Beyond Staging and Restaging
109
TROP SessionThyroid
Committee
Therapeutic Options in Thyroid
Cancer - Radioiodine and Beyond
110
Featured SessionCardiovascular
Committee
Advances in PET-MPI / CT
111
e-Poster Presentation
Session 1Oncology & Theranostics
Committee
PET Diagnostics - Part 1
13:30-15:00
15:00 - 15:10
15:00 - 15:10
15:10 -16:25
201
Plenary 1 incl. Marie Curie
Lecture
Total Body PET
15:10 -16:25
16:25 - 16:35
16:25 - 16:35
16:35 -18:05
301
CME 2Neuroimaging + Physics
Committee
Software Tools and Approaches to Measure
Nuclear Brain Images
302
Joint Symposium 3Oncology & Theranostics
Committee / EAU
Primary Staging of Prostate Cancer
Reloaded
303
Joint Symposium 4Radiation Protection
Committee / EURADOS
Hot Topics in Radiation Protection
304
CTE 2Technologist +
Paediatrics Committee
Update in Paediatric Imaging
305
M2M Track TROP SessionRadiopharmacy +
Translational Molecular Imaging and Therapy
CommitteeCardiology
Translational
306
Cutting Edge Science TrackTROP Session
Dosimetry Committee
Preclinical Dosimetry and Radiobiology
307
Pitfalls & Artefacts 2
Thyroid Committee
Pre- and Post Therapeutic Imaging in
Thyroid Cancer
308
Clinical Oncology Track
TROP SessionOncology & Theranostics
Committee
Interventional Nuclear Medicine - Local
Interventions
309
TROP Session/Featured Session
310
TROP Session/Featured Session
311
e-Poster Presentation
Session 2Oncology & Theranostics
Committee
PET Diagnostics - Part 2
16:35 -18:05
18:05 - 18:10
18:05 - 18:10
18:10 - 19:00
Virtual Congress Opening
18:10 - 19:00
19:00 - 20:00 Welcome Social Hour
19:00 - 20:00
THURSDAY | O c t o b e r 2 2 , 2 0 2 0
Plenary Sessions CME Sessions Joint/Special Symposia Technologist Track M2M Track Cutting Edge Science Track Pitfalls & Artefacts / Teaching Sessions Clinical Oncology Track Mid-Congress-Symposia Further TROP/Featured Sessions e-Poster Presentation Sessions Special Sessions
1312
S C I E N T I F I C P R O G R A M M ES C I E N T I F I C P R O G R A M M EP
RO
GR
AM
ME
OV
ER
VI
EW
| O
CT
OB
ER
22
–3
0,
20
20
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G
F R I D A Y | O c t o b e r 2 3 , 2 0 2 0Time (CEST) Channel 1 Channel 2 Channel 3 Channel 4 Channel 5 Channel 6 Channel 7 Channel 8 Channel 9 Channel 10 Channel 11 Time (CEST)
08:30-08:45 Nuclear Quiz
08:30-08:45
08:45-08:55 Daily Highlights
08:45-08:55
08:55-09:00
08:55-09:00
09:00 - 10:30
401
CME 3Radiopharmacy +
Oncology & Theranostics + Translational Molecular
Imaging and Therapy Committee
Finding the Right PET Companion for ImmunoOncology
402
Joint Symposium 5Oncology & Theranostics
Committee / EHA
Use of PET in Multiple Myeloma
403
Joint Symposium 6Cardiovascular
Committee / ASNC
Detecting Cardiac Toxicity of Cancer
Therapies with Nuclear Imaging
404a
Mini Course 1 (09:00 - 09:50)
Technologist CommitteeNew Developments in Cardiac Imaging
Instrumentation
404b
Mini Course 2 (10:00 - 10:50)
Technologist CommitteeAdvanced Practice in Hybrid Nuclear
Medicine
404c
Mini Course 3(11:00 - 11:50)
Technologist CommitteeAlpha Emitters in
Therapy
405
M2M Track TROP SessionRadiopharmacy +
Translational Molecular Imaging and Therapy
CommitteePharmacokinetics and
Chelators - Best of Both Worlds
406
Cutting Edge Science Track
Featured SessionRadiation Protection
Committee
Patient Radiation Protection
407
Teaching Session 1
TMIT + Physics Committee / EARL
Quantification and Standardisation in
Clinical and Preclinical Molecular Imaging
408
Clinical Oncology Track
Featured Session Oncology & Theranostics
Committee
PRRT for NETs
409
TROP SessionNeuroimaging
Committee
Molecular Imaging of Movement Disorders
410
Featured SessionBone & Joint Committee
Molecular Bone Imaging - Nuclear
Medicine‘s Swiss Army Knife!
411
e-Poster Presentation
Session 3Dosimetry Committee
Clinical Dosimetry Methods
09:00 - 10:30
10:30 - 10:40
10:30 - 10:40
10:40 - 12:10
501
CME 4Bone & Joint Committee
Multimodality Imaging-Based Problem Solving
for Multiple Bone Lesions
502
Joint Symposium 7Neuroimaging Committee /
EAN / ECTRIMS
Multiple Sclerosis - Update in
Neuroimaging
503
Joint Symposium 8Radiopharmacy + Drug
Development Committee / SRS
The Revival of Radiometals
505
M2M Track TROP Session
Drug Development + Translational Molecular Imaging and Therapy
CommitteeIt Takes Place in the
Brain - New Neuro Tracers
506
Cutting Edge Science Track TROP Session
Physics Committee
New Technologies and Imaging Techniques
507
Teaching Session 2
The Uncomfortable Truth - Are Nuclear
Medicine Physicians Viewed as Second Class
Doctors Compared to Radiologists?
508
Clinical Oncology Track
TROP SessionOncology & Theranostics
Committee
PET for Haematological Tumours
509
Featured SessionThyroid
Committee
Parathyroid Imaging - Who
Scores the Best Goals in this Champions
League?
510
Clinical Oncology Track
TROP SessionOncology & Theranostics
Committee
NET Diagnostics
511
e-Poster Presentation
Session 4Cardiovascular
Committee
The Best of Cardiovascular Imaging
in Short
10:40 - 12:10
12:10-12:15
12:10-12:15
12:15-13:45 Lunch Break
12:15-13:45
13:45-13:50
13:45-13:50
13:50 - 15:20
601
CME 5Oncology & Theranostics
Committee
Imaging Hepatobiliary and Pancreatic
Tumours - Pearls, Patterns and Pitfalls
602
Joint Symposium 9Inflammation & Infection
Committee / ESMI / ESCMID
Imaging Pulmonary Fungal Infections
603
Joint Symposium 10Cardiovascular
Committee / JSNM
Nuclear Cardiology Beyond Perfusion
Imaging
604
Technologists Oral Presentations 1 - Featured Session
MATTER - MultidisciplinAry
TechnologisT rEseaRch
605
M2M Track Featured Session
Radiopharmacy + Translational Molecular Imaging and Therapy
Committee
Immune and Microenvironment
Imaging
606
Cutting Edge Science Track TROP Session
Physics Committee
Image Processing - Neurology
607
Pitfalls & Artefacts 3
Dosimetry Committee
Dosimetry as Part of Patient Care
608
Clinical Oncology Track
Featured SessionOncology & Theranostics
CommitteeBCR Detection with Ga-
PSMA and Beyond
609
TROP SessionPaediatrics Committee
Nuclear Playground - Nuclear Medicine in Children
and Adolescents
610
Featured SessionNeuroimaging
Committee
Molecular Brain Tumour Imaging
611
e-Poster Presentation
Session 5Thyroid
Committee
The Thyroid and its Neighbours (The
Parathyroids)
13:50 - 15:20
15:20 -15:30
15:20 -15:30
15:30 -16:45
701
Plenary 2
Cardiac Nuclear Medicine -
Present and Future
15:30 -16:45
16:45-16:55
16:45-16:55
16:55 -18:25
801
CME 6Drug Development + Radiopharmacy + Neuroimaging
CommitteeBloody Hell!!! Impact
on Quantitation of Blood Radiotracer
Measurements
802
Joint Symposium 11Oncology & Theranostics
Committee / ESTRO
How Much PET does Radiation Oncology
Require?
803
Joint Symposium 12Cardiovascular
Committee / EACVI
Selecting the Right Imaging for the Right
Patient in CAD
804
Technologists
Technologist e-Poster Presentation
Session 1
805
M2M Track Featured Session
Radiopharmacy + TMIT + Oncology & Theranostics
Committee Translational
Interventional Nuclear Medicine
806
Cutting Edge Science Track TROP Session
Radiation Protection Committee
Radiation Protection of Staff, and Advances in
Technology
807
Pitfalls & Artefacts 4
Oncology & Theranostics + Inflammation & Infection
CommitteeInterpretation of
Response Monitoring During Immune
Therapy
808
Clinical Oncology Track
TROP SessionOncology & Theranostics
Committee
Breast PET
809
TROP SessionNeuroimaging
Committee
Molecular Imaging of Movement Disorders
810
TROP SessionNeuroimaging
Committee
Molecular Imaging of Movement Disorders
811
Technologists
Technologist e-Poster Presentation
Session 2
16:55 -18:25
1514
S C I E N T I F I C P R O G R A M M ES C I E N T I F I C P R O G R A M M EP
RO
GR
AM
ME
OV
ER
VI
EW
| O
CT
OB
ER
22
–3
0,
20
20
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G
Time (CEST) Channel 1 Channel 2 Channel 3 Channel 4 Channel 5 Channel 6 Channel 7 Channel 8 Channel 9 Channel 10 Channel 11 Time (CEST)
08:30-08:45 Nuclear Quiz
08:30-08:45
08:45-08:55 Daily Highlights
08:45-08:55
08:55 -09:00
08:55 -09:00
09:00 - 10:30
901
CME 7Inflammation & Infection + Paediatrics Committee
Nuclear Medicine in Paediatric Infections
902
Joint Symposium 13Oncology & Theranostics
Committee / EHA
Metabolic Tumour Volume (MTV) in
Lymphoma
903
Joint Symposium 14Drug Development
Committee / SRS
Transporter‘s Imaging
904
CTE 3Technologist + Dosimetry
Committee
Calibration for Instrumentation for
Dosimetry
905
M2M Track TROP Session
Translational Molecular Imaging and Therapy +
Oncology & Theranostics Committee
Image Guided Treatment and Biopsy
906
Cutting Edge Science Track TROP Session
Dosimetry Committee
Dosimetry Methods and Models - Part 1
907
Teaching Session 3
A Practical Guide to MR when Reading PET/MR
908
Clinical Oncology Track
Featured SessionOncology & Theranostics
CommitteePET Diagnostics in
Head Neck Cancers and Melanoma
910
TROP SessionThyroid
Committee
Nuclear Endocrinology in Diagnosis and
Therapy
911
e-Poster Presentation
Session 6Physics
CommitteePhysics - Hardware and
Optimisation
09:00 - 10:30
10:30 -10:40
10:30 -10:40
10:40 -12:10
1001
CME 8Paediatrics Committee
Emergency Conditions in Paediatric Nuclear
Medicine
1002
Joint Symposium 15Thyroid Committee /
ETA-CG
Systemic Therapeutic Options in Advanced
Thyroid Cancer
1003
Joint Symposium 16Bone & Joint Committee
/ EACMFS
Role of Hybrid Imaging in Jaw and Skull
Conditions
1004
CTE 4 Technologist Committee
NET Imaging and Therapy
1005
M2M Track TROP SessionRadiopharmacy +
Translational Molecular Imaging and
Therapy + Drug Development CommitteeNew Kids on the Block -
New Tracers
1006
Cutting Edge Science Track TROP Session
Physics Committee
AI - Radiomics and Modelling
1007
Teaching Session 4
The Intellectual and Emotional Journey to
Radiology and Nuclear Equality
1008
Clinical Oncology Track
Featured SessionOncology & Theranostics
CommitteeBest of Nuclear
Medicine Therapy
1009
Clinical Oncology Track
Featured SessionOncology & Theranostics
CommitteeOnco Diagnostics
Miscellaneous
1010
Featured SessionCardiovascular
Committee
Nuclear Imaging in Cardiac Arrhythmias
1011
e-Poster Presentation
Session 7Inflammation & Infection
CommitteeNuclear Medicine
for Infection & Inflammation - The
Story Continues
10:40 -12:10
Time (CET) Channel 1 Channel 2 Channel 3 Channel 4 Channel 5 Channel 6 Channel 7 Channel 8 Channel 9 Channel 10 Channel 11 Time (CET)
Free
Time (CET) Channel 1 Channel 2 Channel 3 Channel 4 Channel 5 Channel 6 Channel 7 Channel 8 Channel 9 Channel 10 Channel 11 Time (CET)
09:30 -12:15
Mid-Congress- Symposium 1Cardiovascular +
Inflammation & Infection Committee / EACVI
Detecting Cardiac Amyloidosis -
Increasing Role of Nuclear Medicine
Mid-Congress- Symposium 2
Physics + Dosimetry Committee
Artificial Intelligence in Image Acquisition, Reconstruction and
Processing
09:30 -12:15
12:15 -12:20
12:15 -12:20
12:20 -13:50
EANM Young Daily Forum 1
Simply the Best – Presentation Skills for Medical Professionals
12:20 -13:50
13:50 -14:00
13:50 -14:00
14:00 -16:45
Mid-Congress- Symposium 3
Oncology & Theranostics + Radiopharmacy + Drug Development Committee
/ ESMOClinical Development
of Radioligand Therapy
Mid-Congress- Symposium 4
Translational Molecular Imaging and Therapy +
Oncology & Theranostics Committee
Image Guided Surgery
14:00 -16:45
S A T U R D A Y | O c t o b e r 2 4 , 2 0 2 0
S U N D A Y | O c t o b e r 2 5 , 2 0 2 0
M O N D A Y | O c t o b e r 2 6 , 2 0 2 0
1716
S C I E N T I F I C P R O G R A M M ES C I E N T I F I C P R O G R A M M EP
RO
GR
AM
ME
OV
ER
VI
EW
| O
CT
OB
ER
22
–3
0,
20
20
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G
Time (CET) Channel 1 Channel 2 Channel 3 Channel 4 Channel 5 Channel 6 Channel 7 Channel 8 Channel 9 Channel 10 Channel 11 Time (CET)
09:30 -12:15
Mid-Congress- Symposium 5
Oncology & Theranostics Committee
How to Read PET/CT - Different Shades of
Sugar (FDG)
Mid-Congress- Symposium 6Dosimetry + TMIT
+ Onco. & Theran. + Rad. Prot. + Infl. & Inf.
CommitteeImproved Insights into Radiobiology - Key for Radionuclide Therapy
09:30 -12:15
12:15 -12:20
12:15 -12:20
12:20 -13:50
EANM Young Daily Forum 2
I will survive - Managing Work Stress
and Building Your Resilience
12:20 -13:50
13:50 -14:00
13:50 -14:00
14:00 -16:45
Mid-Congress- Symposium 7
Dosimetry + Oncology & Theranostics + Physics
CommitteeLutetium Therapy
Mid-Congress- Symposium 8For Youngsters -
Essential Oncology for Young Nuclear
Medicine Physicians
14:00 -16:45
Time (CET) Channel 1 Channel 2 Channel 3 Channel 4 Channel 5 Channel 6 Channel 7 Channel 8 Channel 9 Channel 10 Channel 11 Time (CET)
09:00 -09:30
Mid-Congress- Symposium 13
(09:00 - 16:00)
Technologist + Dosimetry + Physics Committee
Introduction to Dosimetry
09:00 -09:30
09:30 -12:15
Mid-Congress- Symposium 9
Thyroid + Radiation Protection Committee /
ETA / ESES
Update on Treatment of Hyperthyroidism
Mid-Congress- Symposium 10
Inflammation & Infection Committee
Diagnostic Flowcharts on Musculoskeletal
Infections
09:30 -12:15
12:15 -12:20
12:15 -12:20
12:20 -13:50
EANM Young Daily Forum 3
Nothing else matters - Get your paper
published in a top journal
12:20 -13:50
13:50 -14:00
13:50 -14:00
14:00 -16:45
Mid-Congress- Symposium 11Neuroimaging + Radiopharmacy
CommitteeCurrent State and Future of Tau PET
Imaging
Mid-Congress- Symposium 12For Youngsters -
Emergency During Nuclear Medicine
Procedures - What to Know and What to Do?
14:00 -16:45
T U E S D A Y | O c t o b e r 2 7 , 2 0 2 0
W E D N E S D A Y | O c t o b e r 2 8 , 2 0 2 0
1918
S C I E N T I F I C P R O G R A M M ES C I E N T I F I C P R O G R A M M EP
RO
GR
AM
ME
OV
ER
VI
EW
| O
CT
OB
ER
22
–3
0,
20
20
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G
Time (CET) Channel 1 Channel 2 Channel 3 Channel 4 Channel 5 Channel 6 Channel 7 Channel 8 Channel 9 Channel 10 Channel 11 Time (CET)
13:00 -13:15 Nuclear Quiz
13:00 -13:15
13:15 -13:25 Daily Highlights
13:15 -13:25
13:25 - 13:30
13:25 - 13:30
13:30 -15:00
1101
CME 9Oncology & Theranostics +
Physics Committee
New PET Technologies - Digital
Revolution or Big Bust?
1102
Joint Symposium 17Drug Development Committee / EORTC
Benchside to Bedside and Back - What do we Learn from the Clinic?
1103
Joint Symposium 18Oncology & Theranostics
+ Inflammation & Infection Committee
/ AIO
Imaging Tumour Microenvironment
1104
Technologists Oral Presentations 2 - Featured Session
TOP - Technologist Overview and Practice
impact
1105 1106
Cutting Edge Science Track TROP Session
Dosimetry Committee
Dosimetry Methods and Models - Part 2
1107
Pitfalls & Artefacts 5
Inflammation & Infection Committee
FDG-PET Performed or Suspicious for
Infections and Inflammation,
Including COVID-19
1108
Clinical Oncology Track
TROP SessionOncology & Theranostics
Committee
Detecting BCR with [68Ga]Ga-PSMA
1109
Featured SessionCardiovascular
Committee
Advances in SPECT-MPI
1110
Cutting Edge Science Track
Featured SessionPhysics
Committee
Radiomics
1111
13:30 -15:00
15:00 -15:10
15:00 - 15:10
15:10 - 16:25
1201
Plenary 3
What‘s Cooking? Next Generation
Radiopharmaceuticals
15:10 - 16:25
16:25 - 16:35
16:25 - 16:35
16:35 - 18:05
1301
CME 10 Thyroid
Committee
Radiomics in Thyroid Imaging
1302
Joint Symposium 19Oncology & Theranostics
Committee / ENETS
Impacting the Outcome of High Grade NET
Patients
1303
Joint Symposium 20Neuroimaging
Committee / ECNP
Simultaneous PET/MR Imaging of
Neuroreceptor Systems
1304
Technologists Oral Presentations 3 - Featured Session
BOTH ART - The Beauty Of The HeART and mind
1305
M2M Track Featured Session
Drug Development + Radiopharmacy
Committee
The Revival of Pre-Targeting
1306
Cutting Edge Science Track
Featured SessionPhysics
CommitteeIntra-Operative Nuclear
Medicine
1307
Pitfalls & Artefacts 6
Paediatrics Committee
Pitfalls and Artefacts in Paediatric Nuclear
Medicine
1308
Clinical Oncology Track
TROP SessionOncology & Theranostics
Committee
PET Diagnostics of Lung Cancer and
Mesothelioma
1309
Hot Topic Session
Best Clinical Trials
1309 1311
e-Poster Presentation
Session 8Oncology & Theranostics
Committee
All About the Prostate - Staging, Restaging and
Beyond
16:35 - 18:05
T H U R S D A Y | O c t o b e r 2 9 , 2 0 2 0
Plenary Sessions CME Sessions Joint/Special Symposia Technologist Track M2M Track Cutting Edge Science Track Pitfalls & Artefacts / Teaching Sessions Clinical Oncology Track Mid-Congress-Symposia Further TROP/Featured Sessions e-Poster Presentation Sessions Special Sessions
2120
S C I E N T I F I C P R O G R A M M ES C I E N T I F I C P R O G R A M M EP
RO
GR
AM
ME
OV
ER
VI
EW
| O
CT
OB
ER
22
–3
0,
20
20
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G
Time (CET) Channel 1 Channel 2 Channel 3 Channel 4 Channel 5 Channel 6 Channel 7 Channel 8 Channel 9 Channel 10 Channel 11 Time (CET)
08:30 -08:45 Nuclear Quiz
08:30 -08:45
08:45 -08:55 Daily Highlights
08:45 -08:55
08:55 -09:00
09:00 -10:30
1401
CME 11Oncology & Theranostics + Translational Molecular
Imaging and Therapy Committee
SLN - Past and Future
1402
Joint Symposium 21Drug Development +
Physics Committee / IEEE
Total Body PET Imaging
1403
Joint Symposium 22Paediatrics Committee /
ESPGHAN
Nuclear Medicine Techniques in the Evaluation of GI
Motility in Children
1404
CTE 5Technologist Committee
Departmental Organisation
1405
M2M Track TROP Session
Drug Development + Radiopharmacy
CommitteeNew and Established
Tracers - Prostate only!
1406
Cutting Edge Science Track TROP Session
Dosimetry Committee
Dosimetry for PRRT and PSMA
1407
Teaching Session 5
Oncology & Theranostics Committee
PET/CT Guided Biopsy
1408
Clinical Oncology Track
Featured SessionOncology & Theranostics
CommitteePET Diagnostics of
Gynaecological and GI Tumours
1409
Featured SessionCardiovascular
CommitteeNuclear Imaging in Inflammatory and Infiltrative Cardiovascular
Diseases
1410
TROP Session
General Nuclear Medicine
1411
e-Poster Presentation
Session 9Physics
Committee
Physics - Software and Image Processing
09:00 -10:30
10:30 -10:40
10:30 -10:40
10:40 - 12:10
1501
CME 12Dosimetry Committee
Alpha Particle Therapy Without Imaging -
Options for Dosimetry, the Alpha and Omega
1502
Joint Symposium 23Oncology & Theranostics
Committee / ESDO
New Diagnostic and Therapeutic Frontiers in
Digestive Oncology
1503
Joint Symposium 24Physics + Paediatrics Committee / EFOMP
Technical Advances in Paediatric Dose
Reduction
1504
CTE 6 Technologist Committee
Advanced Competencies
1505
M2M Track Featured SessionTranslational Molecular Imaging and Therapy
+ Radiopharmacy Committee
Targeted Radionuclide Therapy - Trick or Treat?
1506
Cutting Edge Science TrackTROP Session
Physics Committee
Image Reconstruction and Corrections
1507
Teaching Session 6
Cardiovascular Committee
Difficult Cases in Cardiac Imaging
1508
Clinical Oncology Track
Featured SessionOncology & Theranostics
CommitteeProstate Cancer Therapy - PSMA, 223Ra and More...
1509
TROP SessionThyroid
CommitteeIs It or Is It Not Malignant? -
Diagnostic/Predictive Options in Thyroid
Nodules
1510
TROP SessionInflammation & Infection
Committee
Our Army at War - Nuclear Medicine and
COVID-19
1511
e-Poster Presentation
Session 10Neuroimaging
Committee
Molecular Brain Imaging
10:40 - 12:10
12:10 -12:15
12:10 -12:15
12:15 -13:45 Lunch Break
12:15 -13:45
13:45 -13:50
13:45 -13:50
13:50 - 15:20
1601
CME 13Translational Molecular Imaging and Therapy + Physics + Oncology
& Theranostics + Technologist Committee
Radiomics in a Preclininical and a
Clinical Setting
1602
Joint Symposium 25Neuroimaging
Committee / EANO
Immunotherapy in Brain Tumours
1603
Joint Symposium 26Physics + Oncology &
Theranostics Committee / AAPM
Quantitative SPECT - An Essential Tool?
1605 1606
Cutting Edge Science Track TROP Session
Physics Committee
Harmonisation & Standardisation
1607
Pitfalls & Artefacts 7Bone & Joint Committee
Bone SPECT/CT Revisited - Learning an
Old Fox New Tricks
1608
Clinical Oncology Track
TROP SessionOncology & Theranostics
Committee
All About Staging the Prostate
1609
TROP SessionInflammation & Infection
Committee
PET for Infection and Inflammation - A New
Story
1610 1611
e-Poster Presentation
Session 11Oncology & Theranostics
Committee
Nuclear Medicine Therapy Beyond
13:50 - 15:20
15:20 - 15:30
15:20 - 15:30
15:30 - 17:00
1701
CME 14Oncology & Theranostics
Committee
Molecular Drug Imaging of Solid
Tumours Including Microenvironment
1702
Joint Symposium 27TMIT + Oncology & Theranostics + Cardiovascular +
Inflammation & Infection Committee / ESMI
Radar on Immune Cell Imaging
1703
Joint Symposium 28Cardiovascular +
Translational Molecular Imaging and Therapy + Drug Development
Committee / AHANew Approaches for
Cardiovascular Imaging
1704
CTE 7
Technologist Committee
Quality Control of Imaging
Instrumentation
1705
M2M Track TROP Session
Drug Development + Radiopharmacy
CommitteeHot Stuff - Radionuclide
Production
1706
Cutting Edge Science TrackTROP Session
Physics Committee
AI - Image Processing and Data Corrections
1707
Teaching Session 7
Thyroid Committee
Molecular Imaging in Thyroid Nodules
1708
Clinical Oncology Track
TROP SessionOncology & Theranostics
Committee
[177Lu]Lu-PSMA Radioligand Therapy
1709
TROP SessionNeuroimaging
Committee
Novel Molecular Brain Imaging Approaches
1710 1711
e-Poster Presentation
Session 12Oncology & Theranostics
Committee
Onco Diagnostics - Mixed Bag
15:30 - 17:00
17:00 - 17:05
17:00 - 17:05
17:05 -18:25
1801
Honorary Member Award
Marie Curie Award
Plenary 4 - Highlights Lecture
Closing
17:05 -18:25
Plenary Sessions CME Sessions Joint/Special Symposia Technologist Track M2M Track Cutting Edge Science Track Pitfalls & Artefacts / Teaching Sessions Clinical Oncology Track Mid-Congress-Symposia Further TROP/Featured Sessions e-Poster Presentation Sessions Special Sessions
F R I D A Y | O c t o b e r 3 0 , 2 0 2 0
2322
S C I E N T I F I C P R O G R A M M ES C I E N T I F I C P R O G R A M M EP
RO
GR
AM
ME
OV
ER
VI
EW
| O
CT
OB
ER
22
–3
0,
20
20
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G
PRESENTATION TYPESINVITED SPEAKERSInvited talks will be presented in different types of sessions (hereunder in alphabetical order):
CME Session: 90 minutes session, granting CME credits
CTE Session: 90 minutes session, part of the Technologist’s Track
Featured Session: 90 minutes session, invited speakers give an introduction talk on the topic, followed by accepted paper presentations
Joint Symposium: 90 minutes session, jointly organised in cooperation between EANM and its partner societies to provide a multidisciplinary approach
Mini Course: 60 minutes sessions, part of the Technologist’s Track
Pitfalls & Artefacts Session: 90 minutes session, presentation of clinical cases
Plenary Session: 75 minutes session with five or more speakers, being the most prestigious sessions of EANM, allowing everybody to join as no other sessions run in parallel
Mid-Congress Symposium: 180 minutes session incl. coffee break, on Saturday only. Additional CME credits will be granted. Extra charges apply
Mid-Congress Symposium Technologists: full day session incl. two coffee breaks, on Saturday only. Extra charges apply
Teaching Session: 90 minutes session, presentation of clinical cases
PRESENTATION TYPESACCEPTED ABSTRACTS WITH ORAL ONSITE PRESENTATION
PRESENTATION TYPESACCEPTED ABSTRACTS WITH NO ORAL PRESENTATION
Accepted papers of EANM´20 will be presented in different types of session formats (hereunder in alphabetical order):
e-Poster Presentation Session (EPP): Each paper will be presented as uploaded e-Poster in a 5 minutes slot
e-Poster Presentation Session Technologists (TEPP): Each paper will be presented as uploaded e-Poster in a 4 minutes slot
Featured Sessions: Invited speakers give an introduction talk on the topic, followed by accepted papers. Each paper will be presented by using powerpoint slides in a 7 minutes slot
Top Rated Oral Presentation (TROP) Session: Each paper will be presented by using powerpoint slides in a 7 minutes slot
e-Poster (only): Digital posters are uploaded as electronic poster to the e-Poster System. Those papers do not have an onsite presentation but are available throughout the congress in the e-Poster Area. Submitters can be contacted via email through the system.
2524
S C I E N T I F I C P R O G R A M M ES C I E N T I F I C P R O G R A M M EP
RO
GR
AM
ME
OV
ER
VI
EW
| O
CT
OB
ER
22
–3
0,
20
20
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G
1 Monday, October 26, 09:30 – 12:15Detecting Cardiac Amyloidosis – Increasing Role of Nuclear MedicineCardiovascular + Inflammation & Infection Committee / EACVI
2 Monday, October 26, 09:30 – 12:15Artificial Intelligence in Image Acquisition, Reconstruction and ProcessingPhysics + Dosimetry Committee
3 Monday, October 26, 14:00 – 16:45Clinical Development of Radioligand TherapyOncology & Theranostics + Radiopharmacy + Drug Development Committee / ESMO
4 Monday, October 26, 14:00 – 16:45 Image Guided SurgeryTranslational Molecular Imaging & Therapy + Oncology & Theranostics Committee
5 Tuesday, October 27, 09:30 – 12:15How to Read PET/CT – Different Shades of Sugar (FDG)Oncology & Theranostics Committee
6 Tuesday, October 27, 09:30 – 12:15Improved Insights into Radiobiology – Key for Radionuclide TherapyDosimetry + TMIT + Onco. & Theran. + Rad. Prot. & Infl. + Inf. Committee
7 Tuesday, October 27, 14:00 – 16:45Lutetium TherapyDosimetry + Oncology & Theranostics + Physics Committee
8 Tuesday, October 27, 14:00 – 16:45For Youngsters – Essential Oncology for Young Nuclear Medicine Physicians
9 Wednesday, October 28, 09:30 – 12:15Update on Treatment of HyperthyroidismThyroid + Radiation Protection Committee / ETA / ESES
10 Wednesday, October 28, 09:30 – 12:15Diagnostic Flowcharts on Musculoskeletal InfectionsInflammation & Infection Committee
11 Wednesday, October 28, 14:00 – 16:45Current State and Future of Tau PET ImagingNeuroimaging + Radiopharmacy Committee
12 Wednesday, October 28, 14:00 – 16:45For Youngsters – Emergency During Nuclear Medicine Procedures – What to Know and What to Do?
13 Wednesday, October 28, 09:00 – 16:00Mid-Congress Symposium for Technologists - Introduction to DosimetryTechnologist + Dosimetry + Physics Committee
MID-CONGRESSS YM P O S I A
26
S C I E N T I F I C P R O G R A M M EP
RO
GR
AM
ME
OV
ER
VI
EW
| O
CT
OB
ER
22
–3
0,
20
20
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G
S C I E N T I F I C P R O G R A M M E
1 Thursday, October 22, 15:10 – 16:25Total Body PET (incl. Marie Curie Lecture)Chairpersons: Jolanta Kunikowska (PL), Michael Lassmann (DE), Dimitris Visvikis (FR)
» A Game Changer for the Future of PET, Dimitris Visvikis (FR)
» Marie Curie Lecture: Physics and Development of Total Body PET, Simon Cherry (US)
» Is Dynamic PET Imaging Ready for Prime Time?, Irene Buvat (FR)
» Drug Development and Evaluation with Total Body PET, Johannes Czernin (US)
» Scientific Opportunities and their Use, Bernd Pichler (DE)
» Challenge for Technologists, Andrea Santos (PT)
» A Must Have or Another Expensive Luxury Tool?, Ken Herrmann (DE)
» Discussion, All Speakers
2 Friday, October 23, 15:30 – 16:45 Cardiac Nuclear Medicine – Present and FutureChairpersons: Paola Anna Erba (IT ), Wanda Acampa (IT ), Hein Verberne (NL)
» Renew or Fade Away, Hein Verberne (NL)» Do we meet the Clinical Demand?, Wanda Acampa (IT)» MBF – Lost in Clinical Translation?, Ronny Büchel (CH)» Imaging Cardiac Amyloidosis, Sharmila Dorbala (US)
» Endocarditis, Paola Anna Erba (IT)
» Discussion, All Speakers
3 Friday, October 30, 15:10 – 16:25What’s Cooking? Next Generation RadiopharmaceuticalsChairpersons: Jane Sosabowski (UK), Melpomeni Fani (CH), Wolfgang Wadsak (AT)
» What’s New?, Melpomeni Fani (CH)
» FAP-Inhibitors are the Future – For Everything?, Uwe Haberkorn (DE)
» Brain Tracers – Finally for Clinical Application?, Valentina Garibotto (CH)
» Is Theranostics the Future in Nuclear Medicine?, Michael Hofman (AU)
» Do we need Specific Tracers in the Clinics?, Meltem Ocak (TR)
» Why does it take so long?, Jane Sosabowski (UK)
» Discussion, All Speakers
4 Friday, October 30, 17:12 – 18:12Highlights Lecture Moderators: Roland Hustinx (BE), Arturo Chiti (IT )
PLENARYSESSIONS
2928
S C I E N T I F I C P R O G R A M M ES C I E N T I F I C P R O G R A M M EP
RO
GR
AM
ME
OV
ER
VI
EW
| O
CT
OB
ER
22
–3
0,
20
20
E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
1 Thursday, October 22, 13:30 – 15:00Radar on Gynaecological CancersTranslational Molecular Imaging and Therapy + Oncology & Theranostics Committee
2 Thursday, October 22, 16:35 – 18:05 Software Tools and Approaches to Measure Nuclear Brain ImagesNeuroimaging + Physics Committee
3 Friday, October 23, 09:00 – 10:30Finding the Right PET Companion for ImmunoOncologyRadiopharmacy + Oncology & Theranostics + Translational Molecular Imaging and Therapy Committee
4 Friday, October 23, 10:40 – 12:10 Multimodality Imaging-Based Problem Solving for Multiple Bone LesionsBone & Joint Committee
5 Friday, October 23, 13:50 – 15:20Imaging Hepatobiliary and Pancreatic Tumours – Pearls, Patterns and PitfallsOncology & Theranostics Committee
6 Friday, October 23, 16:55 – 18:25Bloody Hell!!! Impact on Quantitation of Blood Radiotracer MeasurementsDrug Development + Radiopharmacy + Neuroimaging Committee
7 Saturday, October 24, 09:00 – 10:30Nuclear Medicine in Paediatric InfectionsInflammation & Infection + Paediatrics Committee
CMESESSIONS
8 Saturday, October 24, 10:40 – 12:10 Emergency Conditions in Paediatric Nuclear MedicinePaediatrics Committee
9 Thursday, October 29, 13:30 – 15:00 New PET Technologies – Digital Revolution or Big Bust?Oncology & Theranostics + Physics Committee
10 Thursday, October 29, 16:35 – 18:05Radiomics in Thyroid ImagingThyroid Committee
11 Friday, October 30, 09:00 – 10:30SLN – Past and FutureOncology & Theranostics + Translational Molecular Imaging and Therapy Committee
12 Friday, October 30, 10:40 – 12:10 Alpha Particle Therapy Without Imaging – Options for Dosimetry, the Alpha and OmegaDosimetry Committee
13 Friday, October 30, 13:50 – 15:20 Radiomics in a Preclininical and a Clinical SettingTranslational Molecular Imaging and Therapy + Physics + Oncology & Theranostics + Technologist Committee
14 Friday, October 30, 15:30 – 17:00Molecular Drug Imaging of Solid Tumours Including MicroenvironmentOncology & Theranostics Committee
Continuing Medical Education Sessions will span over five days of the EANM’20 Virtual Congress. The congress has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 31 European CME credits (ECMEC®s).
3130
S C I E N T I F I C P R O G R A M M ES C I E N T I F I C P R O G R A M M EP
RO
GR
AM
ME
OV
ER
VI
EW
| O
CT
OB
ER
22
–3
0,
20
20
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G
1 Imaging NeuroinflammationDrug Development Committee / EFMC
2 Nano- and Micro-Particles in Nuclear Medicine (Incl. Radioembolisation) Translational Molecular Imaging and Therapy + Drug Development + Radiopharmacy + Oncology & Theranostics Committee / WMIS
3 Primary Staging of Prostate Cancer ReloadedOncology & Theranostics Committee / EAU
4 Hot Topics in Radiation ProtectionRadiation Protection Committee / EURADOS
5 Use of PET in Multiple MyelomaOncology & Theranostics Committee / EHA
6 Detecting Cardiac Toxicity of Cancer Therapies with Nuclear ImagingCardiovascular Committee / ASNC
7 Multiple Sclerosis – Update in NeuroimagingNeuroimaging Committee / EAN / ECTRIMS
8 The Revival of RadiometalsRadiopharmacy + Drug Development Committee / SRS
9 Imaging Pulmonary Fungal InfectionsInflammation & Infection Committee / ESMI / ESCMID
10 Nuclear Cardiology Beyond Perfusion ImagingCardiovascular Committee / JSNM
11 How Much PET does Radiation Oncology Require?Oncology & Theranostics Committee / ESTRO
12 Selecting the Right Imaging for the Right Patient in CADCardiovascular Committee / EACVI
13 Metabolic Tumour Volume (MTV) in LymphomaOncology & Theranostics Committee / EHA
14 Transporter’s ImagingDrug Development Committee / SRS
15 Systemic Therapeutic Options in Advanced Thyroid CancerThyroid Committee / ETA-CG
16 Role of Hybrid Imaging in Jaw and Skull ConditionsBone & Joint Committee / EACMFS
17 Benchside to Bedside and Back – What do we Learn from the Clinic?Drug Development Committee / EORTC
18 Imaging Tumour MicroenvironmentOncology & Theranostics + Inflammation & Infection Committee / AIO
19 Impacting the Outcome of High Grade NET PatientsOncology & Theranostics Committee / ENETS
20 Simultaneous PET/MR Imaging of Neuroreceptor SystemsNeuroimaging Committee / ECNP
21 Total Body PET ImagingDrug Development + Physics Committee / IEEE
22 Nuclear Medicine Techniques in the Evaluation of GI Motility in ChildrenPaediatrics Committee / ESPGHAN
23 New Diagnostic and Therapeutic Frontiers in Digestive OncologyOncology & Theranostics Committee / ESDO
24 Technical Advances in Paediatric Dose ReductionPhysics + Paediatrics Committee / EFOMP
25 Immunotherapy in Brain TumoursNeuroimaging Committee / EANO
26 Quantitative SPECT – An Essential Tool?Physics + Oncology & Theranostics Committee / AAPM
27 Radar on Immune Cell ImagingTranslational Molecular Imaging and Therapy + Oncology & Theranostics + Cardiovascular + Inflammation & Infection Committee / ESMI
28 New Approaches for Cardiovascular ImagingCardiovascular + Translational Molecular Imaging and Therapy + Drug Development Committee / AHA
JOINTSYMPOSIAEANM is again teaming up with its partner societies to fully reflect the multidisciplinarity of Nuclear Medicine.Find the list of Joint Symposia hereunder.
3332
S C I E N T I F I C P R O G R A M M ES C I E N T I F I C P R O G R A M M EP
RO
GR
AM
ME
OV
ER
VI
EW
| O
CT
OB
ER
22
–3
0,
20
20
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G
The EANM Young Daily Forum is the ideal platform for all young talents attending the EANM congress – and those young at heart! It consists of a series of interactive lunch-time sessions open to all participants, particularly those who are at the beginning of their career.Each 1.5 hours’ time slot will focus on a different topic, two of them will be moderated in an interactive way by the professional facilitator Roy Sheppard. Participants will not only benefit from Roy’s vast experience as moderator and speaker, but will also have the opportunity to get to know new people in a relaxed atmosphere. The session on Wednesday will feature two highly experienced editors-in-chief, Arturo Chiti from the EJNMMI and Johannes Czernin from the JNM, as well as the former editor-in-chief of the EJNMMI and world-renowned nuclear medicine expert Ignasi Carriò from Spain. Participation is free for everyone registered to the EANM Annual Congress.
EANM YOUNGDAILY FORUM
1 Monday, October 2612:20 - 13:50
Simply the Best – Presentation Skills for Medical Professionals
2 Tuesday, October 2712:20 - 13:50
I will Survive - Managing Work Stress and Building Your Resilience
3 Wednesday, October 28
12:20 - 13:50
Nothing Else Matters - Get Your Paper Published in a Top Journal
1 Thursday, October 22, 13:30 – 15:00 Unexpected Findings in Brain ImagingNeuroimaging Committee
2 Thursday, October 22, 16:35 – 18:05 Pre- and Post Therapeutic Imaging in Thyroid CancerThyroid Committee
3 Friday, October 23, 13:50 – 15:20 Dosimetry as Part of Patient CareDosimetry Committee
4 Friday, October 23, 16:55 – 18:25 Interpretation of Response Monitoring During Immune TherapyOncology & Theranostics + Inflammation & Infection Committee
5 Thursday, October 29, 13:30 – 15:00FDG-PET Performed or Suspicious for Infections and Inflammation, Including COVID-19Inflammation & Infection Committee
6 Thursday, October 29, 16:35 – 18:05 Pitfalls and Artefacts in Paediatric Nuclear MedicinePaediatrics Committee
7 Friday, October 30, 13:50 – 15:20Bone SPECT/CT Revisited – Learning an Old Fox New TricksBone & Joint Committee
PITFALLS & ARTEFACTSSESSIONSThis year’s seven sessions will span over four days of the congress. Renowned specialists will present interesting cases with challenging findings, either pitfalls and/or artefacts to improve your skillness.
34
S C I E N T I F I C P R O G R A M M EP
RO
GR
AM
ME
OV
ER
VI
EW
| O
CT
OB
ER
22
–3
0,
20
20
E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G
1 Friday, October 23, 09:00 – 10:30 Quantification and Standardisation in Clinical and Preclinical Molecular ImagingTranslational Molecular Imaging and Therapy + Physics Committee / EARL
2 Friday, October 23, 10:40 – 11:40 The Uncomfortable Truth – Are Nuclear Medicine PhysiciansViewed as Second Class Doctors Compared to Radiologists?
3 Saturday, October 24, 09:00 – 10:30 A Practical Guide to MR when Reading PET/MR
4 Saturday, October 24, 10:40 – 11:40 The Intellectual and Emotional Journey to Radiology and Nuclear Equality
5 Friday, October 30, 09:00 – 10:30PET/CT Guided BiopsyOncology & Theranostics Committee
6 Friday, October 30, 10:40 – 12:10 Difficult Cases in Cardiac ImagingCardiovascular Committee
7 Friday, October 30, 13:50 – 15:20Molecular Imaging in Thyroid NodulesThyroid Committee
TEACHINGSESSIONSThis year’s seven teaching sessions will span over three days of the congress. Specialists will present interesting cases and will guide you from patients’ history through diagnosis to treatment options.
EANMRESEARCHLTD (EARL)
Allowing sites to benefit from state-of-the-art PET/CT technology while still ensuring
harmonized scanners performance,
UNIQUE 89Zr PET/CT ACCREDITATIONBased on and derived from the procedures performed for the 18F-FDG PET/CT accreditation which is a prerequisite for
89Zr accreditation
18F STANDARD 2 ACCREDITATION,
EARL is a 100% subsidiary of the EANM, which aims to enhance the quality of nuclear medicine practice for the benefit of public health.
earl.eanm.org
EARL RELEASED
3736
S C I E N T I F I C P R O G R A M M ES C I E N T I F I C P R O G R A M M EP
RO
GR
AM
ME
OV
ER
VI
EW
| O
CT
OB
ER
22
–3
0,
20
20
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G
CUTTING EDGESCIENCE TRACK
M2MTRACK
The Cutting Edge Science Track (formerly known as the International Symposium on Dosimetry and Molecular Radiotherapy) will take place during the 33rd Annual Congress of the European Association of Nuclear Medicine.
M2M – The 7th “From Molecule to Man” Track, covering translational developments in Imaging and Therapy will take place during the 33rd Annual Congress of the European Association of Nuclear Medicine.
The International Symposium on Dosimetry and Molecular Radiotherapy (Do.MoRe) has taken place during the Annual Congress of the European Association of Nuclear Medicine for five consecutive years. It resulted from a series of interesting and important radiopharmaceutical and dosimetry symposia held from 1970 onwards and then continued at the 2004 EANM Congress and the 2009 SNM Congress. These symposia were formerly known as ISTARD (the International Symposium on Targeted Radiotherapy and Radiopharmaceutical Dosimetry). Since 2015, the symposia have been organised annually in parallel with the EANM Congress and the name was changed to Do.MoRe in order to emphasise the importance of dosimetry.
This year, it was decided together with the chairs of the committees involved to reorganize this separate track within the EANM Congress. The aim of this reorganization is to bring together all of the disciplines concerned with physics, dosimetry and radiobiology and to provide attendees with the most cutting edge innovations in these fields. Medical physics is a complex specialty which covers a broad range of areas ranging from the development of new detectors/imaging equipment to image reconstruction and quantification, dosimetry, tracer kinetics, radiobiology and radiation protection. Today’s new challenges include the integration of Artificial
Intelligence (AI) into most of these technical areas as well as its eventual implementation in clinical practice. Therefore, we decided to rename this track and give priority to the presentation of the most innovative aspects of all of these disciplines. In addition, one major objective is to enhance the interaction between all of these disciplines given their prominent role within the field of nuclear medicine by promoting a deeper interdisciplinary scientific discussion. Consequently, there will be more featured sessions which combine guest speakers and paper presentations and which involve clinical contributors.
The Cutting Edge Science Track will start with many featured sessions (combining guest speakers and paper presentations) throughout the main congress days and an outstanding plenary session concerning “Total Body PET”. In addition, some mid-congress symposia, namely with “Artificial Intelligence in Image Acquisition, Reconstruction and Processing”, “Lutetium Therapy”, and “Improved insights on Radiobiology” have been planned.
The EANM Committees of Dosimetry, Radiation Protection, and Physics will coordinate the scientific programme for the meeting jointly with the support of the Congress Chair.
We are looking forward to welcoming you to EANM’20. Be part of it!
Mark Konijnenberg, EANM Dosimetry CommitteeSøren Holm, EANM Radiation Protection CommitteeDimitris Visvikis, EANM Physics Committee
Fijs van Leeuwen, EANM Translational Molecular Imaging & Therapy CommitteeMarianne Patt, EANM Radiopharmacy CommitteeJohnny Vercouillie, EANM Drug Development Committee
The 7th M2M Track will take place during the 33rd Annual Congress of the European Association of Nuclear Medicine.
Since 2014, the M2M sessions have constituted one of the main pillars in the programme of the annual EANM Congress. With the M2M track the EANM aims to actively stimulate multidisciplinary interplay between the various scientific disciplines concerned with molecular/nuclear imaging and therapy. By providing a platform for a wide range of scientific and medical aspects, M2M sessions have succeeded in attracting scientists (e.g. radiochemists, physisists and biologists), industry representatives and clinicians alike. With that, a successful stepping stone for translational science has been established.
The M2M track comprises a series of plenary lectures, CME sessions, symposia and focused scientific sessions, all of which have the aim of connecting fundamental research with unmet medical needs and vice versa.
The EANM Committees for Translational Molecular Imaging and Therapy, Drug Development and Radiopharmacy jointly coordinate the scientific programme of the M2M track, while the EANM Executive Office handles organisational matters.
We hope you will enjoy the sessions of the M2M Track 2020!
3938
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G
T E C H N O L O G I S T S ‘ P R O G R A M M ET E C H N O L O G I S T S ‘ P R O G R A M M E
Dear colleagues and friends,On behalf of the European Association of Nuclear Medicine Technologist Committee, I kindly invite you to join us at the 33rd Annual Congress of the EANM.
This year, the EANM congress will once again provide a full program dedicated to technologists. The focus will be on topics that are important for current practice in the nuclear medicine field, a sector in which scientific and technological advancements have been great. A wide range of subjects will be covered during the Congress. These will include quality control and calibration of instrumentation for imaging and dosimetry, updates in pediatric and neuroendocrine tumor imaging and topics such as departmental organization and advanced competencies.
As in previous years, the chosen topics will be addressed in seven Continuous Technologist Education (CTE) sessions and three mini-courses (MC), during which specialists will share their expertise and knowledge with the audience.
We are very proud to announce that one talk as part of the “Total Body PET” plenary on Thursday will focus on “Challenges for Technologists”.
Another new feature at this year’s edition will be the Mid-Congress Symposium for Technologists. The “Introduction to Dosimetry“ session will be a full-day symposium.
Owing to its visibility and the number of attendees, the EANM Annual Congress offers an excellent opportunity to share original research and clinical work, and the EANM-TC will be accepting abstracts from nuclear medicine technologists and related clinical scientists. To provide space for participants to present the results of their work, three oral presentation sessions and two e-poster presentation sessions will take place during the congress. As in recent years, we expect that these sessions will be of very high quality and offer a useful means to promote and share work. As an additional motivating factor, an award will be given to the best three oral presentations as well as the best e-poster presentation.
With my best regards,Andrea Santos Chair, EANM Technologist Committee
LETTER OFI N V I TAT I O Nby the Chair of the Technologist Committee
Andrea SantosChair, EANM Technologist Committee
4140
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G
T E C H N O L O G I S T S ‘ P R O G R A M M ET E C H N O L O G I S T S ‘ P R O G R A M M E
TECHNOLOGISTS’TRACK
1 Thursday, October 22, 13:30 – 15:00 Tech Guide Launch » 08:00 – 08:10 Opening Technologist Track » 08:10 – 09:30 Technologist Committee
2 Thursday, October 22, 16:35 – 18:05 Update in Paediatric ImagingTechnologist + Paediatrics Committee
3 Saturday, October 24, 09:00 – 10:30 Calibration for Instrumentation for DosimetryTechnologist + Dosimetry Committee
4 Saturday, October 24, 10:40 – 12:10 NET Imaging and TherapyTechnologist Committee
13 Wednesday, October 28, 09:00 – 16:00 Mid-Congress Symposium for Technologists – Introduction to DosimetryTechnologist + Dosimetry + Physics Committee
1 Friday, October 23, 09:00 – 09:50 New Developments in Cardiac Imaging InstrumentationTechnologist Committee
2 Friday, October 23, 10:00 – 10:50 Advanced Practice in Hybrid Nuclear MedicineTechnologist Committee
3 Friday, October 23, 11:00 – 11:50 Alpha Emitters in TherapyTechnologist Committee
In addition to the CTE Sessions the Technologist’s Track includes 3 Mini Courses:
Mid-Congress Symposium
CTE Sessions
The Technologist Committee places a massive effort into delivering the most up-to date and highest quality educational initiatives. All sessions of this track are aimed specifically at the technologists’ audience.
5 Friday, October 30, 09:00 – 10:30Departmental OrganisationTechnologist Committee
6 Friday, October 30, 10:40 – 12:10Advanced CompetenciesTechnologist Committee
7 Friday, October 30, 13:50 – 15:20Quality Control of Imaging InstrumentationTechnologist Committee
4342
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G
e-POSTER AREA + O N D E MA N D S E S S I O N S
S C I E N T I F I C P R O G R A M M E
e-Poster Presentation SessionsAll accepted e-Posters can be viewed in the digital e-Posters Area. For any additional questions, the e-Posters submitters can be contacted via email through the e-Poster Area System.
On demand sessionsAll passed session can be viewed at any time one demand throughout the whole congress. Please be aware, that CME credits can only be collected for live streamed sessions.
45
PR
OG
RA
MM
E O
VE
RV
IE
W |
OC
TO
BE
R 2
2 –
30
, 2
02
0
E A N M ’ 2 0 W O R L D L E A D I N G M E E T I N G
E X H I B I T I O N
Developing Targeted Radionuclide Therapies in Precision Oncology.
www.itm.ag
PRECISELY FOR ME.
Dedicated to giving cancer patients better answers than “maybe”.
VISIT OUR
SATELLITE SYMPOSIUM
“Challenges and Innovative
Approaches in the
Management of Osteoblastic
Metastatic Disease.”
October 23, 2020, 16:55 – 18:25 (CET), Channel 10 at Virtual EANM 2020
INDUSTRY E X H I B I T I O NThe industry exhibition will be held virtually and all participants will have access throughout all congress days.You will have the chance to interactively get in touch with the companies.
The industry exhibition is available at any time on October 22-30, 2020
O C T O B E R 2 2 – 3 0 , 2 0 2 0 | V I R T U A L 47O C T O B E R 2 2 – 3 0 , 2 0 2 0 | V I R T U A L46
R E G I S T R AT I O NR E G I S T R AT I O N
EA
NM
’20
WO
RL
D L
EA
DIN
G M
EE
TIN
G
EA
NM
’20
WO
RL
D L
EA
DIN
G M
EE
TIN
G
Registration Fees in Euro (excl. VAT)
EANM Member* 140,-
Non-Member 280,-
EANM Junior Member* 1) 80,-
Junior Non-Member 1) 160,-
EANM Nurse/Technologist Member* 2) 45,-
Nurse/Technologist Non-Member 2) 95,-
EANM Associate Member* 140,-
Associate Non-Member 280,-
Student 3) 20,–
Mid-Congress Symposium ** 90,–
*Only members who have paid the full amount of their membership fee by May 31 of the respective year, will benefit from the reduced „Member“ registration fee for the Annual Congress of the EANM.
** reduced price for Nurse/Technologists, Students and Juniors
1) Physician or other scientist in training, up to the age of 38 (maximum age on November 1, 2020). For Junior Non-Members: confirmation letter (in English) incl. signature of Head of Department and copy of passport showing date of birth are indispensable for proof of status.
2) Nurse, healthcare technologist or laboratory technologist, being employed in a respective current professional occupation. Confirmation letter (in English) incl. signature of Head of Department is indispensable for proof of status.
3) Student without any academic degree, up to the age of 26 (maximum age on November 1, 2020), even if a degree has been achieved in a completely different field and/or has no relevance to the current professional occupation. Confirmation letter (in English) incl. signature of Head of Department and copy of passport showing date of birth are indispensable for proof of status. Students already holding an academic degree (and not older than 38 years of age on November 1, 2020) must register as Juniors!
To register for EANM’ 20 please use our online registration platform: eanm20.eanm.org
REGISTRATIONFEES
O C T O B E R 2 2 – 3 0 , 2 0 2 0 | V I R T U A L 49O C T O B E R 2 2 – 3 0 , 2 0 2 0 | V I R T U A L48
G E N E R A L I N F O R M AT I O NG E N E R A L I N F O R M AT I O N
EA
NM
’20
WO
RL
D L
EA
DIN
G M
EE
TIN
G
EA
NM
’20
WO
RL
D L
EA
DIN
G M
EE
TIN
G
GENERALI N F O R MAT I O NCALL FOR ABSTRACTSThe deadline for abstract submission is April 25, 2020.Authors will be notified about the acceptance of abstracts by email on June 26, 2020.
CERTIFICATE OF ATTENDANCE
Certificates of Attendance will be available in your myEANM area after the congress.
CONGRESS CLOSING
The Congress Closing will be broadcasted right after the Highlights Lecture on October 30, 2020. All registered delegates can join online.
CME CREDITES & CERTIFICATES
To acquire CME credits, an evaluation form must also be completed for each session attended.
The EANM’20 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 31 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
The EANM’20 – Mid-Congress Symposia have been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 2 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
CONGRESS APP
No congress app will be provided. All registered participants have access to the virtual online platform via their myEANM Area login.
E-POSTER AREA
As every year, the e-Poster Area gives you the possibility to read all uploaded e-Posters of EANM’20. You can search for authors, topics and keywords.
LANGUAGE
The congress language is English. No simultaneous translation will be provided.
EANM OFFICE
The congress office will be available during all congress days via email and phone. Further details will be published soon.
DISCLAIMERIn the event the congress has to be cancelled by the organisers because of force majeure, the registration fee, and any other payments for services ordered through the registration process will be partially refunded or forfeited, which is subject to the commitments of the congress organisers at that time.
EANM EXECUTIVE OFFICE
Schmalzhofgasse 261060 Vienna, AustriaPhone: +43 1 890 44 27Fax: +43 1 890 44 27-9Email: [email protected]: www.eanm.org
EANM MEMBERS’ ASSEMBLY
The Members’ Assembly will be held virtually onSaturday, October 17, 2020 from 16:30-18:30.
Please note: Only EANM members in good standing (having paid their membership dues for the year 2020) are eligible to attend the Members’ Assembly.
INTERNATIONAL MEETINGS ANDANNOUNCEMENT SECTION
Visit the International Meetings and Announcement Board to get information on upcoming events in Nuclear Medicine and more.
VIRTUAL CONGRESS OPENING & WELCOME HAPPY HOUR
All registered delegates are invited to attend virtually the
Virtual Congress Opening & Welcome Happy HourThursday, October 22, 2020 – 18:00-20:00
VIRTUAL INDUSTRY EXHIBITION
Inside our fully virtual conference halls, the user can enter a real-life animated exhibition hall while being able to move around and navigate interactively.Visitors will be able to communicate with booth staff via state-of-the-art chat tools, see models of the newest products, participate in raffles and quizzes and even find dedicated job offerings.All Members of the EANM Nuclear Medicine Community can participate without closing times 24/7 to this active meeting and job-market tool completely free of charge.
Special thanks to the EANM Committees and the ESMIT Working Groups for their continuing support.
European School of Multimodality Imaging and Therapy
Course Programme2021
Please note that the information given above is subject to change.For regular updates, please visit the EANM website or
subscribe to the ESMIT vNewsletter.
Acknowledgement
eanm.org/esmit
The ESMIT leadership likes to thank all contributors of this initiative. Special thanks to the EANM Committees and the ESMIT Project Groups for their continuing support.
Dosimetry Practical Implementation of Clinical Dosimetry in NM Therapy Feb 2021
Oncology Therapy Assessment Mar 2021
Physics Advanced Features of Quantification Apr 2021
Neurology Quantification in Neurology Apr 2021
Bone & Joint Post-Operative Skeleton Jun 2021
Oncology Prostate Cancer (advanced) Sep 2021
Thyroid Management of Thyroid Cancer (advanced) Nov 2021
Tba Theranostics Dec 2021
Speakers: Ian Armstrong, John Dickson, Stephan Nekolla, Dimitris Visvikis
Moderator: Michel Koole
Nuclear Imaging Technology: Where we came from, where we are and
where we are heading
ESMIT Live Webinar series - to be continued!
Speakers: Mark Lubberink, Roberto Sciagra
Moderator: Christoph Rischpler
PET MPI: Tracers, Equipment, Protocols, Flow Quantification, Viability
Plac
e:Pl
ace:
PHYS
ICS
CARD
IOLO
GY
Stay tuned for more ESMIT Live Webinars coming up in 2021!
For more information visit the ESMIT Booth of EANM’20
O C T O B E R 2 2 – 3 0 , 2 0 2 0 | V I R T U A L52
U S E F U L A D D R E S S E S
SCIENTIFIC PROGRAMME EANM Executive OfficeMs. Susanne KoebeSchmalzhofgasse 26/5, 1060 Vienna, AustriaPhone: +43 1 890 44 27 Fax: +43 1 890 44 27-9Email: [email protected]: eanm20.eanm.org
INDUSTRY EXHIBITION EANM Executive OfficeMr. Andreas Felser (Congress Manager)Mrs. Silvia Zippelius (Exhibition & Sponsoring)Schmalzhofgasse 26/5, 1060 Vienna, AustriaPhone: +43 1 890 44 27 Fax: +43 1 890 44 27-9Email: [email protected]: eanm20.eanm.org
REGISTRATION EANM Executive OfficeMs. Petra NeubauerSchmalzhofgasse 26/5, 1060 Vienna, AustriaPhone: +43 1 890 44 27 Fax: +43 1 890 44 27-9Email: [email protected]: eanm20.eanm.org
USEFULCO N TAC TS